News und Analysen
Jacobs Solutions Q3 Earnings Call Highlights
Key Points
- Interested in Jacobs Solutions Inc.? Here are five stocks we like better.
- Jacobs raised its fiscal 2026 outlook for the third consecutive quarter, targeting 9.5%–10% adjusted net
Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 05. August 2026
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 05. August 2026
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel
Viasat Q1 Earnings Call Highlights
Key Points
- Interested in Viasat Inc.? Here are five stocks we like better.
- Viasat maintained its fiscal 2027 outlook despite first-quarter revenue falling 1% to $1.2 billion and adjusted
Rigel Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Rigel Pharmaceuticals, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Rigel reported $78.7 million in revenue and $17.3 million in net income, with
Arrowhead Pharmaceuticals Q3 Earnings Call Highlights
Key Points
- Interested in Arrowhead Pharmaceuticals, Inc.? Here are five stocks we like better.
- Plozasiran delivered positive Phase III results in severe hypertriglyceridemia, reducing
IPG Photonics Q2 Earnings Call Highlights
Key Points
- Interested in IPG Photonics Corporation? Here are five stocks we like better.
- IPG Photonics reported strong second-quarter growth: Revenue rose 11% year over year to $279 million
ConvaTec Group H1 Earnings Call Highlights
Key Points
- Interested in ConvaTec Group PLC? Here are five stocks we like better.
- ConvaTec maintained its 2026 targets after delivering 5% first-half organic revenue growth excluding
BWX Technologies Q2 Earnings Call Highlights
Key Points
- Interested in BWX Technologies, Inc.? Here are five stocks we like better.
- BWXT reported strong Q2 results, with revenue up 18% to $902 million, adjusted EPS up 5% to $1.70, and
ClearPoint Neuro Q2 Earnings Call Highlights
Key Points
- Interested in ClearPoint Neuro, Inc.? Here are five stocks we like better.
- Q2 revenue increased 18% to $10.9 million, driven by neurosurgery navigation, therapy products and capital
Advanced Energy Industries Q2 Earnings Call Highlights
Key Points
- Interested in Advanced Energy Industries, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 30% year over year to $574 million, while non-GAAP EPS
Süss MicroTec Aktie: 45 Millionen für Advanced-Packaging-Zentrum
Der Halbleiterzulieferer Süss MicroTec treibt seine Expansionspläne voran, während die Aktie am Kapitalmarkt zuletzt…
Der Beitrag Süss MicroTec Aktie: 45 Millionen für Advanced-Packaging-Zentrum
LyondellBasell Industries Q2 Earnings Call Highlights
Key Points
- Interested in LyondellBasell Industries N.V.? Here are five stocks we like better.
- Second-quarter results improved sharply: LyondellBasell reported $2.1 billion in EBITDA and $4.30
Eastman Chemical Q2 Earnings Call Highlights
Key Points
- Interested in Eastman Chemical Company? Here are five stocks we like better.
- Eastman expects stronger earnings growth in the second half of 2026, driven by volume gains, improved
Ingram Micro Q2 Earnings Call Highlights
Key Points
- Interested in Ingram Micro Holding Corporation? Here are five stocks we like better.
- Record Q2 performance: Ingram Micro reported $14.53 billion in revenue, up 13.6% year over year
"There are no new eras; excesses are never permanent." --Bob Farrell (Rule #3)
TIPPING POINT: BUY LTPZ
TIPPING POINT: BUY LTPZ (July 31, 2026): As I had described in my recent postings, U.S. government debt has become unusually undervalued, with many U.S
Solstice Advanced Mat Q2 Earnings Call Highlights
Key Points
- Interested in Solstice Advanced Mat? Here are five stocks we like better.
- Solstice Advanced Materials exceeded Q2 guidance, with sales up 11% year over year to $1.148 billion and
Kyndryl Shareholders Approve Board, Pay Plan and Auditor at 2026 Annual Meeting
Key Points
- Interested in Kyndryl Holdings, Inc.? Here are five stocks we like better.
- Kyndryl shareholders approved all four proposals at the 2026 annual meeting, including six director
Madrigal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Madrigal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Rezdiffra sales rose 71% year over year to $364.3 million in Q2 2026, with nearly $1.3 billion in
Leonardo DRS Q2 Earnings Call Highlights
Key Points
- Interested in Leonardo DRS, Inc.? Here are five stocks we like better.
- Second-quarter results strengthened: Revenue rose 10% to $913 million, while adjusted EBITDA increased 33% to
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
Multibeam unterzeichnet Absichtserklärung über Förderung von 140 Mio. USD mit US-Handelsministerium
Absichtserklärung ebnet den Weg für eine strategische Initiative zur Entwicklung von Fine-Pitch-Prozessabläufen für die energieeffiziente heterogene Chipintegration der nächsten Generation
Multibeam unterzeichnet Absichtserklärung über Förderung von 140 Mio. USD mit US-Handelsministerium
Absichtserklärung ebnet den Weg für eine strategische Initiative zur Entwicklung von Fine-Pitch-Prozessabläufen für die energieeffiziente heterogene Chipintegration der nächsten Generation
EQS-News: NanoRepro AG: Jahresabschluss 2025 veröffentlicht – Gruppe mit konsolidiertem Umsatz von rund 16 Mio. EUR auf Wachstumskurs
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across